Publication Date:
2023
abstract:
Aggressive SM + AML has limited therapeutic options. Even a strong combination of decitabine–venetoclax–midostaurin has a transient effect on AML and a mitigated effect on SM. Larger series are required to identify the best therapeutic strategy
Iris type:
14.a.1 Articolo su rivista
List of contributors:
Fazio, Manlio; Vetro, Calogero; Markovic, Uroš; Duminuco, Andrea; Parisi, Marina; Maugeri, Cinzia; Mauro, Elisa; Laura Parrinello, Nunziatina; Stagno, Fabio; Villari, Loredana; Maria Triolo, Anna; Stella, Stefania; Palumbo, Giuseppe A.; Di Raimondo, Francesco; Romano, Alessandra; Zanotti, Roberta
Published in: